Traunstein, Germany

Kai Oliver Donsbach

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Pharmazell Gmbh. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kai Oliver Donsbach. Retrieved from https://idiyas.com/inventor/kai-oliver-donsbach-0mx0p46i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Kai Oliver Donsbach

Introduction

Kai Oliver Donsbach is a notable inventor based in Traunstein, Germany. He has made significant contributions to the field of biochemistry, particularly in the hydroxylation of steroids. His work has implications for various applications in pharmaceuticals and biotechnology.

Latest Patents

Donsbach holds a patent for a method for the hydroxylation of steroids. This invention relates to an enzyme and method for the hydroxylation of a 7-deoxysteroid, which has the general formula (I). This innovative approach enhances the efficiency of steroid modification, which is crucial for developing new therapeutic agents.

Career Highlights

Donsbach is currently associated with Pharmazell GmbH, a company that specializes in pharmaceutical development. His role at the company allows him to apply his expertise in enzymatic processes to advance drug development. His contributions have been instrumental in pushing the boundaries of current biotechnological methods.

Collaborations

Donsbach collaborates with Nicole Staunig, who is also involved in research and development at Pharmazell GmbH. Their partnership exemplifies the collaborative spirit in scientific research, where diverse expertise can lead to groundbreaking innovations.

Conclusion

Kai Oliver Donsbach is a prominent figure in the field of biochemistry, with a focus on steroid hydroxylation. His patent and work at Pharmazell GmbH highlight his commitment to advancing pharmaceutical science. His contributions are paving the way for future innovations in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…